The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease

The relationship between interleukin-6 and C-reactive protein was evaluated in patients with benign (n=59) and malignant (n=86) prostate disease. The correlation coefficients for patients with benign prostatic disease and prostate cancer were r(s)=0.632, P<0.001 and r(s)=0.663, P<0.001, respec...

Descripción completa

Detalles Bibliográficos
Autores principales: McArdle, P A, McMillan, D C, Sattar, N, Wallace, A M, Underwood, M A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410056/
https://www.ncbi.nlm.nih.gov/pubmed/15505624
http://dx.doi.org/10.1038/sj.bjc.6602211
Descripción
Sumario:The relationship between interleukin-6 and C-reactive protein was evaluated in patients with benign (n=59) and malignant (n=86) prostate disease. The correlation coefficients for patients with benign prostatic disease and prostate cancer were r(s)=0.632, P<0.001 and r(s)=0.663, P<0.001, respectively. These results indicate that the relationship between interleukin-6 and C-reactive protein is similar in patients with benign and malignant prostate disease.

Ejemplares similares